BlueRock Therapeutics to start cell therapy trial for Parkinson’s disease
BlueRock Therapeutics is all set to initiate Phase I Study of MSK-DA01 Cell Therapy for advanced Parkinson’s disease (PD) after…
Latest Neurology
-
2 days
-
4 days
-
2 weeks
-
2 weeks
-
2 days
-
4 days
-
2 weeks
-
2 weeks
Ionis begins clinical trial of antisense medicine for ALS treatment
Ionis Pharmaceuticals has initiated a Phase III clinical trial of antisense medicine ION363 in patients with amyotrophic lateral sclerosis (ALS)…
Latest News
View More
Roche to halt dosing in Huntington’s disease trial with tominersen
Roche has decided to discontinue dosing in the Phase III GENERATION HD1 study of investigational antisense therapy, tominersen, in manifest Huntington’s disease (HD). Licensed from…
Australia to support clinical trials for mental illness treatments
The Australian Government is launching a competitive grant round of $11.6m (A$15m) to kick-start clinical trials to develop treatments for mental illness. The A$15m Innovative…
Pinteon reports positive data of trial for neurodegenerative tauopathy
Biotechnology company Pinteon Therapeutics has announced results from its Phase I study of novel tau antibody, PNT001, in treating neurodegenerative…
Concert’s schizophrenia treatment trial fails to meet endpoints
Concert Pharmaceuticals has announced that its Phase II clinical trial of CTP-692 as an adjunctive treatment in patients with schizophrenia…
Apnimed doses first patient in obstructive sleep apnea drug trial
Clinical-stage pharma company Apnimed has announced the dosing of the first patient in a Phase II clinical trial of its…
Seelos Therapeutics begins dosing in study of SLS-002
Clinical-stage biopharma firm Seelos Therapeutics has dosed the first patients in its registrational 'Proof of Concept' study to evaluate SLS-002…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Latest Content
View More
Alzheimer’s trials: Biogen and Lilly’s amyloid-targeting drugs race for FDA approval
With Eli Lilly’s donanemab and Biogen’s aducanumab jockeying for position in the race for key regulatory approvals, the so-called amyloid…
Neurology trends: Stroke leads Twitter mentions in Q4 2020
The top tweeted terms are the trending industry discussions happening on Twitter by key individuals (influencers) as tracked by the…
Strategikon Pharma Announces New Software Release of Clinical Maestro
Strategikon Pharma announced a global update for its Clinical Maestro™ platform that advances capabilities for tracking out of scope services…
How to Improve CRO Oversight by Bringing Your TMF In-House
To facilitate virtual TMF inspections and improve efficiency, the European Medicines Agency (EMA) encourages sponsors to provide inspectors direct system…
Why is Translation Software So Important for Clinical Trial Translations?
Translation software is essential for performing high-quality translation, especially in the clinical trial and medical field, as it facilitates and…